Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma

By            

Oncology Letters, Vol. 8, Iss. 3, 2014-01 ,pp. : 1302-1306

Spandidos Publications

Access to resources Recommend Favorite

Metformin use and improved response to therapy in esophageal adenocarcinoma

By Skinner Heath D.   McCurdy Matthew R.   Echeverria Alfredo E.   Lin Steven H.   Welsh James W.   O'Reilly Michael S.   Hofstetter Wayne L.   Ajani Jaffer A.   Komaki Ritsuko   Cox James D.   Sandulache Vlad C.   Myers Jeffrey N.   Guerrero Thomas M.  

Acta Oncologica, Vol. 52, Iss. 5, 2013-06 ,pp. : 1002-1009

Informa Healthcare

Access to resources Recommend Favorite

Preoperative CA 19-9 and the Yield of Staging Laparoscopy in Patients with Radiographically Resectable Pancreatic Adenocarcinoma

By Maithel Shishir  

Annals of Surgical Oncology, Vol. 15, Iss. 12, 2008-12 ,pp. : 3512-3520

Springer Publishing Company

Access to resources Recommend Favorite

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation

By Katz Matthew  

Annals of Surgical Oncology, Vol. 17, Iss. 7, 2010-07 ,pp. : 1794-1801

Springer Publishing Company

Access to resources Recommend Favorite

Predictors of Response and Survival in Locally Advanced Adenocarcinoma of the Pancreas Following Neoadjuvant GTX with or Without Radiation Therapy

By  

The Oncologist, Vol. 23, Iss. 1, 2018-01 ,pp. : 4-e10

John Wiley & Sons Inc

Access to resources Recommend Favorite